Virus-like particles for vaccination against cancer.

Détails

Ressource 1Télécharger: 31456339_BIB_FA959DAE62AF.pdf (9086.81 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_FA959DAE62AF
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Virus-like particles for vaccination against cancer.
Périodique
Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
Auteur(s)
Mohsen M.O., Speiser D.E., Knuth A., Bachmann M.F.
ISSN
1939-0041 (Electronic)
ISSN-L
1939-0041
Statut éditorial
Publié
Date de publication
01/2020
Peer-reviewed
Oui
Volume
12
Numéro
1
Pages
e1579
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Résumé
Active immunotherapy of cancer aims to treat the disease by inducing effective cellular and humoral immune responses. Virus-like particle-based vaccines have evolved dramatically over the last few decades, greatly reducing morbidity and mortality of several infectious diseases and expectedly preventing cervical cancer caused by human papilloma virus. In contrast to these broad successes of disease prevention, therapeutic cancer vaccines remain to demonstrate clinical benefit. Yet, several preclinical and clinical trials have revealed promising results and are paving the way for medical breakthroughs. This study reviews and discusses the recent preclinical development and clinical trials in this field. This article is categorized under: Biology-Inspired Nanomaterials > Protein and Virus-Based Structures Nanotechnology Approaches to Biology > Nanoscale Systems in Biology.
Mots-clé
cancer, vaccine, virus like particles
Pubmed
Web of science
Open Access
Oui
Création de la notice
17/09/2019 14:28
Dernière modification de la notice
15/01/2021 8:12
Données d'usage